Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024 at 14:42 PM EDT
J&J's cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to AI.
